Cherry Imaging, a developer of a high-resolution scanner for aesthetic applications on both face and body, will launch its technology at the AAD annual conference in Washington, DC.
The company recently won the IMCAS Innovation 2019 which was held in Paris. The technology, alongside 15 startups in the medical space, was presented to industry leaders, venture capitalists and physicians, and it was awarded 1st prize.
The technology is designed to bring scientific data measurements to the hands of physicians for accurate, objective, and traceable aesthetic and medical treatments on both face and body. The platform combines a powerful, easy-to-use skin morphology model scanner with an innovative Trace proprietary software that together can objectively measure changes in the skin – from scars, fillers and Botox, to body shaping, cellulite treatments, skin rejuvenation and pigmentation, according to the company in a media release.
Cherry’s lightweight, handheld scanner captures thousands of three-dimensional images from multiple field views and multiple angles, all within a single, one-click scan. The images can be captured from wherever the doctor is with the patient — no lighting adjustments or angling necessary. The software then analyzes the data, providing the doctor with accurate feedback for comparable analyses over time.
The company plans to expand the applications to additional dermatological conditions including clinical dermatology. In the near future, the company will release the new version of Trace – Trace Everywhere – which will enable access from any location and platform, such as any iPad or smart phone, the release continues.
[Source(s): Cherry Imaging, PR Newswire]
